CCTA-Guided CABG vs CAG-Guided CABG
Official title: Coronary Computed Tomography Angiography-Based Versus Coronary Angiography-Based Coronary Artery Bypass Grafting: A Multicenter Pragmatic Non-Inferiority Randomized Controlled Trial
Run by Ruijin Hospital · NCT07769008 · Data updated 2026-11-12
This study tests whether planning CABG with a non-invasive CCTA scan works as well as planning with the standard invasive CAG approach for people with blocked heart arteries.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 826 (estimated) |
| Sponsor | Ruijin Hospital Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | August 17, 2026 |
| Main results expected | August 2029 |
| Study ends | August 2029 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT07769008 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults referred for CABG who can safely undergo either CCTA or CAG planning and provide informed consent.
✕Probably not a fit
Patients who cannot undergo CCTA or CAG due to contraindications or who experience outcomes not influenced by planning method may see no difference.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter pragmatic trial compares two ways of planning coronary artery bypass grafting: using coronary computed tomography angiography (CCTA) versus using coronary angiography (CAG). Participants are randomized to have either planning method guide their CABG, and both groups receive CABG per local protocol. The trial looks at 1-year outcomes including heart attacks, strokes, need for additional procedures, and length of hospital stay, with an internal pilot to assess feasibility and protocol adherence. Primary feasibility outcomes cover screening, consent, randomization, recruitment rate, concordance between planned and actual revascularization, and follow-up completion at 7 and 30 days. The study also explores graft-related outcomes and early morbidity and mortality. Lead sponsor is Ruijin Hospital, with the study conducted at Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Why it matters
Potential benefit: If successful, patients and clinicians could have a non-invasive, equally effective way to plan CABG, potentially reducing procedure-related risks and discomfort.
How similar studies have gone: Prior studies in imaging-guided planning have shown promise, but this direct non-inferiority comparison for CABG planning is relatively novel and exploratory in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Referred to CABG treatment Exclusion Criteria: * Under the age of 18 years * Unable to provide informed consent * Emergency CABG * Redo-CABG * Prior PCI with coronary stent implantation and unable to undergo photon counting CCTA. * Cardiogenic shock * Unable to undergo CAG or CCTA examination or deemed unsuitable by the investigator, such as: Known allergy to iodinated contrast media; Active hyperthyroidism or uncontrolled thyroid disease; Estimated glomerular filtration rate (eGFR) \< 30 mL/min/1.73 m²; Atrial fibrillation with rapid ventricular response or severe arrhythmias not amenable to rate control; * Pregnancy, lactation, or childbearing potential without effective contraception in female participants * Concurrent participation in another interventional trial
Where it's running
-
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, China Recruiting
Study contacts
- Study coordinator: Yunpeng Zhu, MD
- Email: zyp12220@rjh.com.cn
- Phone: 0086-02164370045
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing heart imaging techniques for coronary artery disease
This study is testing if a new heart imaging method can better identify problems in patients suspected of having coronary artery disease compared to a traditional imaging technique.
-
Short-term high-dose rosuvastatin effects on coronary plaque using photon-counting CT
This trial tests whether a short course of intensified rosuvastatin (40 mg) changes coronary plaque composition and flow on photon‑counting coronary CT in statin‑naive adults with stable chest pain and mild atherosclerosis.
-
AI tools for predicting high-risk coronary plaques
This study is testing a new AI tool to see if it can better predict dangerous plaque buildup in the arteries of people with heart disease.
-
Using CCTA to improve management of stable chest pain
This study is testing if using a special heart scan called CCTA can help doctors better manage stable chest pain and reduce serious heart problems for patients suspected of having blocked arteries.
-
Comparing single and multiple arterial grafts in women with heart disease
This study is testing whether using one or more artery grafts during heart surgery can lead to better health outcomes and quality of life for women with heart disease.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.